These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 35306281)

  • 1. Targeting toll-like receptors on T cells as a therapeutic strategy against tumors.
    Ding R; Jiao A; Zhang B
    Int Immunopharmacol; 2022 Jun; 107():108708. PubMed ID: 35306281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Direct and indirect role of Toll-like receptors in T cell mediated immunity.
    Xu D; Liu H; Komai-Koma M
    Cell Mol Immunol; 2004 Aug; 1(4):239-46. PubMed ID: 16225766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Innate immunity: structure and function of TLRs].
    Delneste Y; Beauvillain C; Jeannin P
    Med Sci (Paris); 2007 Jan; 23(1):67-73. PubMed ID: 17212934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-Like Receptor Signaling and Its Role in Cell-Mediated Immunity.
    Duan T; Du Y; Xing C; Wang HY; Wang RF
    Front Immunol; 2022; 13():812774. PubMed ID: 35309296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
    Ma Z; Zhang E; Yang D; Lu M
    Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of T- and B-cell intrinsic toll-like receptors to the adaptive immune response in viral infectious diseases.
    Zhang E; Ma Z; Lu M
    Cell Mol Life Sci; 2022 Oct; 79(11):547. PubMed ID: 36224474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toll-like receptor regulation of effector T lymphocyte function.
    Reynolds JM; Dong C
    Trends Immunol; 2013 Oct; 34(10):511-9. PubMed ID: 23886621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-cell intrinsic Toll-like receptor signaling: implications for cancer immunotherapy and CAR T-cells.
    Nouri Y; Weinkove R; Perret R
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34799397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-cell receptor activation of human CD4(+) T cells shifts the innate TLR response from CXCL8(hi) IFN-γ(null) to CXCL8(lo) IFN-γ(hi).
    Akhade AS; Qadri A
    Eur J Immunol; 2015 Sep; 45(9):2628-37. PubMed ID: 26205220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The contribution of direct TLR signaling to T cell responses.
    Rahman AH; Taylor DK; Turka LA
    Immunol Res; 2009; 45(1):25-36. PubMed ID: 19597998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems.
    Kobayashi K; Inohara N; Hernandez LD; Galán JE; Núñez G; Janeway CA; Medzhitov R; Flavell RA
    Nature; 2002 Mar; 416(6877):194-9. PubMed ID: 11894098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Toll-Like Receptors in Skin Host Defense, Psoriasis, and Atopic Dermatitis.
    Sun L; Liu W; Zhang LJ
    J Immunol Res; 2019; 2019():1824624. PubMed ID: 31815151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives.
    Mukherjee S; Patra R; Behzadi P; Masotti A; Paolini A; Sarshar M
    Front Immunol; 2023; 14():1244345. PubMed ID: 37822929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-Like Receptors in Natural Killer Cells and Their Application for Immunotherapy.
    Noh JY; Yoon SR; Kim TD; Choi I; Jung H
    J Immunol Res; 2020; 2020():2045860. PubMed ID: 32377528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redundant and regulatory roles for Toll-like receptors in Leishmania infection.
    Chauhan P; Shukla D; Chattopadhyay D; Saha B
    Clin Exp Immunol; 2017 Nov; 190(2):167-186. PubMed ID: 28708252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate and intrinsic antiviral immunity in skin.
    Kawamura T; Ogawa Y; Aoki R; Shimada S
    J Dermatol Sci; 2014 Sep; 75(3):159-66. PubMed ID: 24928148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triggering of toll-like receptor signaling pathways in T cells contributes to the anti-tumor efficacy of T cell responses.
    Salem ML
    Immunol Lett; 2011 Jun; 137(1-2):9-14. PubMed ID: 21352854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toll-Like Receptors (TLRs), NOD-Like Receptors (NLRs), and RIG-I-Like Receptors (RLRs) in Innate Immunity. TLRs, NLRs, and RLRs Ligands as Immunotherapeutic Agents for Hematopoietic Diseases.
    Wicherska-Pawłowska K; Wróbel T; Rybka J
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delineating the Role of Toll-Like Receptors in the Neuro-inflammation Model EAE.
    Fallarino F; Gargaro M; Mondanell G; Downer EJ; Hossain MJ; Gran B
    Methods Mol Biol; 2016; 1390():383-411. PubMed ID: 26803641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.